Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: MolDX: Proteomics Testing (A59641) - R4 - Effective May 30, 2024 May 30, 2024
Open Meeting Announcement Botulinum Toxin Injections, Micro Invasive Glaucoma Surgery (MIGS), Artificial Intelligence Enabled Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) - June 27, 2024 May 30, 2024
Billing and Coding: MolDX: SMPD1 Genetic Testing (A55627) Retirement - Effective May 21, 2024 May 30, 2024
Billing and Coding: MolDX: MCOLN1 Genetic Testing (A55283) Retirement - Effective May 23, 2024 May 30, 2024
Billing and Coding: MolDX: L1CAM Gene Sequencing (A55277) Retirement - Effective May 24, 2024 May 30, 2024
Billing and Coding: MolDX: Fragile X (A55241) Retirement - Effective May 23, 2024 May 30, 2024
Billing and Coding: MolDX: FANCC Genetic Testing (A55183) Retirement - Effective May 21, 2024 May 30, 2024
Billing and Coding: MolDX: FDA-Approved EGFR Tests (A54422) - R6 - Effective May 30, 2024 May 30, 2024
Billing and Coding: MolDX: 9p21 Genotype Test (A55092) Retirement - Effective May 24, 2024 May 30, 2024
Local Coverage Determinations (LCDs) Finalized - Effective July 7, 2024 May 23, 2024
MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic Services (A59743) - R1 - Effective May 23, 2024 May 23, 2024
Billing and Coding: MolDX: HAX1 Gene Sequencing (A55249) Retirement - Effective May 14, 2024 May 23, 2024
MolDX: Blood Product Molecular Antigen Typing (L38331) - R4 - Effective May 23, 2024 May 23, 2024
Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) Testing (A55088) Retirement - Effective May 14, 2024 May 23, 2024
Billing and Coding: MolDX: HEXA Gene Analysis (A55255) Retirement - Effective May 8, 2024 May 16, 2024
Billing and Coding: MolDX: BCKDHB Gene Test (A55099) Retirement - Effective May 8, 2024 May 16, 2024
Billing and Coding: MolDX: IKBKAP Genetic Testing (A55612) Retirement - Effective May 7, 2024 May 16, 2024
Self-Administered Drug Exclusion List (A53032) - R35 - Effective June 23, 2024 May 09, 2024
Billing and Coding: MolDX: TP53 Gene Tests (A55484) Retirement - Effective May 1, 2024 May 09, 2024
Billing and Coding: MolDX: TERC Gene Tests (A55611) Retirement - Effective May 1, 2024 May 09, 2024